SRNE

Sorrento Therapeutics News

Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -4.87% 2.54 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.69 2.47 2.73 2.48 2.67
more quote information »

Recent News

Date Time Source Heading
8/09/202216:02EDGARNotification That Quarterly Report Will Be Submitted Late..
8/09/202211:20EDGARConfidential Treatment Order (ct Order)
8/03/202209:00GLOBESorrento Completes Successfully the SAD Study and Initiates..
7/25/202206:20TRMNSorrento Therapeutics (SRNE) Receives a Buy from Dawson..
7/19/202214:53GLOBESorrento Therapeutics Announces the FDA IND Clearance of..
7/13/202208:16TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks:..
7/07/202209:30GLOBEScilex Holding Company, a Sorrento Company, Has Entered A..
7/05/202214:04GLOBEScilex Holding Company, a Sorrento Company, announces that..
6/24/202215:38GLOBESorrento Therapeutics, Inc. announces the appointment of the..
6/14/202217:16EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202210:33GLOBEScilex Holding Company, a Sorrento Company, enters into an..
6/03/202209:20GLOBESorrento Therapeutics Announces First Subject Dosed in a..
6/03/202209:01EDGARCurrent Report Filing (8-k)
6/03/202209:00GLOBEScilex Holding Company, a Sorrento Company, Announces..
6/02/202209:00GLOBEScilex Holding Company, a Sorrento Company, announces..
6/02/202206:30PRNUSCaris Life Sciences, Prostate Cancer Clinical Trial..
6/01/202209:00GLOBESichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and Levena..
5/23/202209:06EDGARFiling of Certain Prospectuses and Communications in..
5/20/202217:15EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202216:03EDGARCurrent Report Filing (8-k)
5/18/202209:30GLOBEScilex, a Sorrento Company, Announces Initiation of a Phase..
5/18/202209:00GLOBESorrento Therapeutics, Inc. Appoints Former Roche Executive..
5/18/202205:01TRMNAnalysts Offer Insights on Healthcare Companies: SAB..
5/17/202211:00GLOBESorrento’s License Partner, Lee’s Pharm, Announces Full..
5/17/202209:00GLOBESorrento Announces FDA Authorization to Proceed With Phase 2..
5/16/202209:00GLOBEScilex Holding Company, a Sorrento Company, and Vickers..
5/11/202209:00GLOBEScilex, a Sorrento Company, Highlights Safety Data From..
5/05/202220:05GLOBEScilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102..
5/05/202216:49EDGARQuarterly Report (10-q)
5/03/202209:15GLOBELevena Biopharma, A Sorrento Company, Announces Positive..
5/02/202209:00GLOBESorrento Announces Full Enrollment of Phase I Study of..
4/28/202209:01EDGARCurrent Report Filing (8-k)
4/28/202209:00GLOBEScilex Holding Company a Majority-Owned Subsidiary of..
4/27/202209:00GLOBEScilex Holding Company, a majority-owned subsidiary of..
4/25/202212:46GLOBEScilex Holding Company, a majority-owned subsidiary of..
4/25/202209:30GLOBESorrento Announces FDA Authorization to Proceed with Phase 1..
4/25/202209:00GLOBEDr. Henry Ji, Sorrento Therapeutics’ Chairman and CEO and..
4/12/202221:15GLOBEScilex Holding Company, a majority-owned subsidiary of..
4/07/202219:00QUIVRNew Corporate Lobbying data: $SRNE recently disclosed $150..
4/04/202209:01EDGARCurrent Report Filing (8-k)
4/04/202209:00GLOBEScilex Holding Company, a majority-owned subsidiary of..
3/31/202209:29SEEKSorrento granted FDA clearance to start late-stage trial for..
3/31/202209:00GLOBESorrento Reports FDA Clearance for the Commencement of a..
3/29/202209:00GLOBETurning Point Therapeutics Announces Appointment of Brian..
3/25/202209:51SEEKSorrento subsidiary Scilex to enter deal for $5 billion..
3/25/202209:00GLOBEScilex Holding Company, a majority-owned subsidiary of..
3/25/202206:25TRMNAnalysts Offer Insights on Healthcare Companies: Sorrento..
3/20/202217:26GLOBESorrento Reports Promising Results With a Universal Chimeric..
3/18/202216:36EDGARCurrent Report Filing (8-k)
3/18/202209:24SEEKSorrento Therapeutics sciatica pain treatment meets primary..


Your Recent History
NASDAQ
SRNE
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now